OBJECTIVES: To examine the relationship between a single-item indicator of subjective well-being (SWB) and (1) medical conditions frequently associated with adverse clinical outcomes, (2) health-related quality of life and depressive symptoms, (3) global self-rated health (SRH), and (4) increased risk of adverse clinical outcomes. METHODS: Self-reports of depressive symptoms and HRQoL were obtained by mail surveys from 2,317 men and women with hypertension and coronary artery disease. Subjects rated their overall SWB at clinic visits. Mean scores of subjects reporting excellent SWB were compared to scores of subjects rating SWB for HRQoL domains and depressive symptom scores using ANOVA. The association between SWB and individual endpoints was assessed using the chi(2) test. The adjusted association between SWB and the composite endpoint of mortality, nonfatal stroke or nonfatal myocardial infarction was estimated using binary logistic regression. RESULTS: Excellent SWB was associated with fewer depressive symptoms and more favorable HRQoL scores. The proportion of subjects suffering one of the adverse health outcomes within 1 year increased (p < 0.002) with poorer reported SWB. One-year mortality was higher in subjects with poor/fair SWB (5.7%) than in subjects with good or excellent SWB (3.4 and 4.5%, respectively; p = 0.05). Subjects rating their SWB as poor/fair were more likely to suffer a nonfatal stroke (unadjusted RR = 2.67, 95% CI = 1.24, 5.74). SWB added to the prediction of adverse outcomes after adjusting for demographics, baseline medical conditions, and SRH (OR = 2.49, 95% CI = 1.51, 4.11). CONCLUSION: A global indicator of SWB may be a useful addition to a screening instrument for identifying persons at increased risk for adverse health outcomes.
OBJECTIVES: To examine the relationship between a single-item indicator of subjective well-being (SWB) and (1) medical conditions frequently associated with adverse clinical outcomes, (2) health-related quality of life and depressive symptoms, (3) global self-rated health (SRH), and (4) increased risk of adverse clinical outcomes. METHODS: Self-reports of depressive symptoms and HRQoL were obtained by mail surveys from 2,317 men and women with hypertension and coronary artery disease. Subjects rated their overall SWB at clinic visits. Mean scores of subjects reporting excellent SWB were compared to scores of subjects rating SWB for HRQoL domains and depressive symptom scores using ANOVA. The association between SWB and individual endpoints was assessed using the chi(2) test. The adjusted association between SWB and the composite endpoint of mortality, nonfatal stroke or nonfatal myocardial infarction was estimated using binary logistic regression. RESULTS: Excellent SWB was associated with fewer depressive symptoms and more favorable HRQoL scores. The proportion of subjects suffering one of the adverse health outcomes within 1 year increased (p < 0.002) with poorer reported SWB. One-year mortality was higher in subjects with poor/fair SWB (5.7%) than in subjects with good or excellent SWB (3.4 and 4.5%, respectively; p = 0.05). Subjects rating their SWB as poor/fair were more likely to suffer a nonfatal stroke (unadjusted RR = 2.67, 95% CI = 1.24, 5.74). SWB added to the prediction of adverse outcomes after adjusting for demographics, baseline medical conditions, and SRH (OR = 2.49, 95% CI = 1.51, 4.11). CONCLUSION: A global indicator of SWB may be a useful addition to a screening instrument for identifying persons at increased risk for adverse health outcomes.
Authors: A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware Journal: JAMA Date: 1989-08-18 Impact factor: 56.272
Authors: Ralph A H Stewart; Fiona M North; Teena M West; Katrina J Sharples; R John Simes; David M Colquhoun; Harvey D White; Andrew M Tonkin Journal: Eur Heart J Date: 2003-11 Impact factor: 29.983
Authors: Christina M DuBois; Oriana Vesga Lopez; Eleanor E Beale; Brian C Healy; Julia K Boehm; Jeff C Huffman Journal: Int J Cardiol Date: 2015-05-21 Impact factor: 4.164
Authors: William A Wood; Jennifer Le-Rademacher; Karen L Syrjala; Heather Jim; Paul B Jacobsen; Jennifer M Knight; Muneer H Abidi; John R Wingard; Navneet S Majhail; Nancy L Geller; J Douglas Rizzo; Mingwei Fei; Juan Wu; Mary M Horowitz; Stephanie J Lee Journal: Cancer Date: 2015-10-06 Impact factor: 6.860
Authors: Anthony A Bavry; R David Anderson; Yan Gong; Scott J Denardo; Rhonda M Cooper-Dehoff; Eileen M Handberg; Carl J Pepine Journal: Hypertension Date: 2009-12-07 Impact factor: 10.190
Authors: I Rouch; E Achour-Crawford; F Roche; C Castro-Lionard; B Laurent; G Ntougou Assoumou; R Gonthier; J-C Barthelemy; B Trombert Journal: J Nutr Health Aging Date: 2014-11 Impact factor: 4.075
Authors: Yan Gong; Eileen M Handberg; Tobias Gerhard; Rhonda M Cooper-Dehoff; L Douglas Ried; Julie A Johnson; Carl J Pepine Journal: Clin Cardiol Date: 2009-11 Impact factor: 2.882